IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
19 hedge funds and large institutions have $1.84M invested in Interpace Biosciences, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$18.2K | |
| 2 | +$1.09K | |
| 3 | +$753 | |
| 4 |
Morgan Stanley
New York
|
+$38 |
Top Sellers
| 1 | -$38.9K | |
| 2 | -$11K | |
| 3 | -$3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$903 |
| 5 |
Goldman Sachs
New York
|
-$565 |